Adjuvant therapy in renal cell carcinoma: is it the right strategy to inhibit VEGF?

Despite several clinical trials have assessed different agents in the adjuvant setting, renal cell carcinoma (RCC) still remains a disease orphan of an effective adjuvant treatment. In fact, systemic therapies targeting angiogenesis that have been observed to be effective in metastatic setting faile...

Full description

Saved in:
Bibliographic Details
Published in:Transl Androl Urol
Main Authors: Mollica, Veronica, Rizzo, Alessandro, Di Nunno, Vincenzo, Santoni, Matteo, Cheng, Liang, Lopez-Beltran, Antonio, Scarpelli, Marina, Cimadamore, Alessia, Montironi, Rodolfo, Massari, Francesco
Format: Artigo
Language:Inglês
Published: AME Publishing Company 2021
Subjects:
Review Article on Update on Molecular Classification and Individualized Treatments of Genitourinary Tumors
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8039625/
https://ncbi.nlm.nih.gov/pubmed/33850792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau-20-1125
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items